This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Sharps Compliance Reports $5.4 Million In Revenue In Third Quarter Fiscal 2013

Stocks in this article: SMED

Focused sales and marketing initiatives delivers momentum

Retail market billings increased $0.3 million, or 24.7%, to $1.7 million, compared with the prior-year period. The year-over-year increase reflected increased sales of the Complete Needle Collection & Disposal System and TakeAway Environmental Return Systemâ„¢ solutions. Billings to this market were up 21.6% over the trailing second quarter, driven by carryover orders from the 2012 flu shot season and advance orders for the 2013 flu shot season as well as increased sales of the Complete Needle Collection & Disposal System and TakeAway Environmental Return Systemâ„¢ solutions.

Professional market billings grew $0.1 million, or 7.4%, to $0.9 million in the third quarter of fiscal 2013. The growth in this market was a direct result of the Company's targeted telemarketing initiatives and promotional activities to educate doctors, dentists and veterinarians of the significant cost advantage and convenience of the Company's Sharps ® Recovery System when compared with the traditional pick-up service for the small quantity generator sector. The Company's inside and online sales channel, which is focused primarily on the Professional market, realized a 22.0% increase in billings to $0.8 million in the fiscal 2013 third quarter from $0.6 million in the prior year period. Offsetting the growth from the inside and online sales channel were lower sales for the quarter through the distributor network due to the timing of orders.

Third quarter pharmaceutical market billings decreased $0.5 million, or 61%, to $0.3 million. Billings to this market tend to be program related and, therefore, can be highly variable from quarter to quarter until programs mature. The comparable period for the fiscal 2012 third quarter was atypically strong as it included the roll-out period for two new Patient Support Programs and the initial launch of a third Patient Support Program.

Third quarter Home Health Care billings were $1.5 million, up 4.1% over the prior year period, while Assisted Living/Hospitality billings were $0.4 million, up 10.9% for the quarter.

2 of 7

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,416.85 +225.48 1.31%
S&P 500 2,021.25 +19.09 0.95%
NASDAQ 4,683.4070 +45.4130 0.98%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs